Tag: Aptorum
Presenting Aptorum Group Limited at the HC Wainwright Annual Global Investment Conference to be held September 13-16, 2022
Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM), a clinical-stage biopharmaceutical company dedicated to addressing unmet medical needs in oncology, autoimmune diseases and infectious diseases, today announces that Mr. Darren…
Aptorum Group Announces Clinical Validation Update of its Liquid Biopsy Infectious Disease Detection RPIDD Technology
Aptorum Group Limited (Nasdaq: APM, Euronext Paris: APM) (“Aptorum Group” or “Aptorum”), a clinical-phase biopharmaceutical company focused on innovative technologies for the treatment and diagnosis of infectious diseases, announces that…